DE68909412T2 - Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen. - Google Patents

Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
DE68909412T2
DE68909412T2 DE89906364T DE68909412T DE68909412T2 DE 68909412 T2 DE68909412 T2 DE 68909412T2 DE 89906364 T DE89906364 T DE 89906364T DE 68909412 T DE68909412 T DE 68909412T DE 68909412 T2 DE68909412 T2 DE 68909412T2
Authority
DE
Germany
Prior art keywords
butyl
salts
methyl
carbonate
glycosaminoglycans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89906364T
Other languages
German (de)
English (en)
Other versions
DE68909412D1 (de
Inventor
Maurizio Acquasaliente
Pozzo Alma Dal
Santis Francesco De
Paolo Ferruti
Monique Sarret
Giancarlo Sportoletti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT20854/88A external-priority patent/IT1219704B/it
Priority claimed from IT8947985A external-priority patent/IT1231915B/it
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Publication of DE68909412D1 publication Critical patent/DE68909412D1/de
Application granted granted Critical
Publication of DE68909412T2 publication Critical patent/DE68909412T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE89906364T 1988-06-03 1989-05-30 Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen. Expired - Fee Related DE68909412T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20854/88A IT1219704B (it) 1988-06-03 1988-06-03 Sali di glicosaminoglicani,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT8947985A IT1231915B (it) 1989-05-24 1989-05-24 Sali di glicosaminoglicani, procedimento per la loro preparazione e relative composizioni farmaceutiche

Publications (2)

Publication Number Publication Date
DE68909412D1 DE68909412D1 (de) 1993-10-28
DE68909412T2 true DE68909412T2 (de) 1994-02-03

Family

ID=26327686

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89906364T Expired - Fee Related DE68909412T2 (de) 1988-06-03 1989-05-30 Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.

Country Status (13)

Country Link
US (1) US5264425A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0423151B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH04500377A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR920700232A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU630359B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1335375C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE68909412T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK286190D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU208029B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN169470B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MC (1) MC2098A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ229403A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1989012070A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668116A (en) * 1987-03-19 1997-09-16 Anthropharm Pty. Limited Anti-inflammatory compounds and compositions
CA1327354C (en) * 1987-03-19 1994-03-01 David Cullis-Hill Anti-inflamatory compounds and compositions
IT1237518B (it) * 1989-11-24 1993-06-08 Renato Conti Eparine supersolfatate
IT1242604B (it) * 1990-11-13 1994-05-16 Alfa Wassermann Spa Sali di glicosaminoglicani con esteri di aminoacidi, loro preparazione e formulazioni farmaceutiche che li contengono.
IT1274021B (it) * 1994-02-28 1997-07-14 Italfarmaco Spa Diesteri dell'acido carbonico ad attivita' antivirale ed antinfiammatoria
WO1996013270A1 (en) * 1994-10-28 1996-05-09 The Trustees Of The University Of Pennsylvania Heparin, compositions and methods of use therefore
ZA978537B (en) 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
JP2003503083A (ja) 1999-07-01 2003-01-28 サイオス，インコーポレーテッド アミロイド関連疾患の予防及び治療
EP2402753A1 (en) 2002-03-11 2012-01-04 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
CA2483271A1 (en) * 2002-04-25 2003-11-06 Momenta Pharmaceuticals, Inc. Methods and products for mucosal delivery
US8719242B2 (en) * 2003-08-29 2014-05-06 Sap Ag System and method for a database access statement interceptor
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
US8592393B2 (en) * 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
WO2009059284A2 (en) * 2007-11-02 2009-05-07 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8435795B2 (en) * 2010-01-19 2013-05-07 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
EP2558506B1 (en) 2010-04-16 2019-06-26 Momenta Pharmaceuticals, Inc. Tissue targeting
CN103096870B (zh) 2010-06-17 2017-04-19 动量制药公司 调节毛发生长的方法和组合物
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2014193818A1 (en) 2013-05-28 2014-12-04 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
WO2022168085A1 (en) * 2021-02-02 2022-08-11 Ramot At Tel-Aviv University Ltd. Lipids suitable for nucleic acid delivery

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA676310A (en) * 1963-12-17 Union Carbide Corporation Diamines and process for preparation
US2830932A (en) * 1952-12-06 1958-04-15 Abbott Lab N,n'dibenzylethylene diamine salt of heparin
GB768524A (en) * 1954-04-20 1957-02-20 Erba Carlo Spa Improvements in or relating to the production of heparin
US3162673A (en) * 1960-12-28 1964-12-22 Union Carbide Corp Bis (aminoaliphatic) carbonates and process for preparation
US3244594A (en) * 1962-01-12 1966-04-05 Egyt Gyogyszervegyeszeti Gyar 1, 6-bis-(beta-chloro-ethyl-amino)-1, 6-deoxy-d-mannitol heparinate
US3661923A (en) * 1968-10-18 1972-05-09 Rohm & Haas Polyfunctional polyol ester oxazolidines
US4324739A (en) * 1979-04-10 1982-04-13 Ciba-Geigy Corporation Dimethylamino derivatives and their use
US4352913A (en) * 1979-04-10 1982-10-05 Ciba-Geigy Corporation Dimethylamino derivatives and their use
DE3020220A1 (de) * 1980-05-28 1981-12-03 Theodor Prof. Dr. 4400 Münster Eckert Organische salze des heparin, der heparinoide, ihre herstellung und sie enthaltende arzneimittel
SE8103137L (sv) * 1981-05-19 1982-11-20 Pharmacia Ab Polymer med kvartera aminogrupper
US4604376A (en) * 1982-04-21 1986-08-05 Research Corporation Enteric compounds and complexes
US4654327A (en) * 1982-04-21 1987-03-31 Research Corp. Quaternary ammonium complexes of heparin
US4510135A (en) * 1982-04-21 1985-04-09 Research Corporation Orally administered heparin
US4581058A (en) * 1982-09-02 1986-04-08 Buckman Laboratories, Inc. Polymeric quaternary ammonium compounds and their uses
US4506081A (en) * 1982-09-02 1985-03-19 Buckman Laboratories, Inc. Polymeric quaternary ammonium compounds and their uses
FR2538404B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1982-12-28 1985-08-23 Anic Spa
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
DE3402927A1 (de) * 1984-01-28 1985-08-08 Pfeifer & Langen, 5000 Köln Zellkulturmikrotraeger, verfahren zu seiner herstellung und seine verwendung zum zuechten von verankerungsabhaengigen zellen
US4703042A (en) * 1984-05-21 1987-10-27 Bodor Nicholas S Orally active heparin salts containing multivalent cationic units
IT1208509B (it) * 1985-03-13 1989-07-10 Mediolanum Farmaceutici Srl Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico.
HU193769B (en) * 1985-06-04 1987-11-30 Richter Gedeon Vegyeszet Sodium-exchanging process for producing pharmaceutically acceptable heparinates applicable even for injections
IT1188184B (it) * 1985-08-14 1988-01-07 Texcontor Ets Sali ammonici quaternari di polisaccaridi ad attivita' ipocolesterolemizzante
US4981955A (en) * 1988-06-28 1991-01-01 Lopez Lorenzo L Depolymerization method of heparin

Also Published As

Publication number Publication date
US5264425A (en) 1993-11-23
MC2098A1 (fr) 1991-02-15
WO1989012070A1 (en) 1989-12-14
DE68909412D1 (de) 1993-10-28
HU208029B (en) 1993-07-28
DK286190A (da) 1990-11-30
NZ229403A (en) 1991-02-26
CA1335375C (en) 1995-04-25
IN169470B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-10-19
EP0423151B1 (en) 1993-09-22
JPH04500377A (ja) 1992-01-23
HU893408D0 (en) 1991-10-28
DK286190D0 (da) 1990-11-30
HUT57237A (en) 1991-11-28
AU630359B2 (en) 1992-10-29
KR920700232A (ko) 1992-02-19
EP0423151A1 (en) 1991-04-24
AU3746489A (en) 1990-01-05

Similar Documents

Publication Publication Date Title
DE68909412T2 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
DE68917009T2 (de) Sulfaminoderivate von Chondroitinsulfat, Dermatansulfat und Hyaluronsäure und ihre pharmakologischen Eigenschaften.
DE69016383T2 (de) Supersulfatierte Heparine.
DE3529529C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD251355A5 (de) Verfahren zur herstellung von oligosacchariden
DE69831805T2 (de) Dextranderivate, verfahren zu deren herstellung und verwendungen als arzneimittel mit spezifischer, biologischer wirkung
EP0508220B1 (de) Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel
DE69223153T2 (de) Dermatansulfat mit trombolytischer wirkung und arzneiformen welche dieses enthalten
DD285606A5 (de) Verfahren zur herstellung von selektiv o-azylierten glucosaminoglycanen
DE60208528T2 (de) Hochsulfatierte derivate von k5-polysacchariden und ihre herstellung
DE2311131C3 (de) Amidinopenicillansäureester, Verfahren zu deren Herstellung und pharmazeutische Mittel
EP0217372A2 (de) Neue polyoxygenierte Labdan-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Medikamente
CH661746A5 (de) Verfahren zur herstellung von humaninsulin oder von threonin b30-estern von humaninsulin, oder von einem salz oder einem metallkomplex derselben, sowie diese ester.
DE2425983B2 (de) Sulfonsaeuresalze von acylcholinen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzung
EP0353668B1 (de) Verbessertes Verfahren zur Herstellung von N,N-Bis(alkoxyalkyl)-pyridin -2,4-dicarbonsäurediamiden
DE69109913T2 (de) Cephalosporinzwischenverbindungen, Verfahren zu ihrer Herstellung sowie zur Herstellung ihrer Endprodukte.
DD297165A5 (de) Neue sulfatierte polysaccharide, physiologisch vertraegliche salze davon und verfahren zu ihrer herstellung
DE69121058T2 (de) Salze von Glykosaminoglykanen mit Aminosäureester, ihre Herstellung sowie sie enthaltende pharmazeutische Zusammensetzungen
DE2112057A1 (de) Neue Penicillinester
DE69313138T2 (de) Oligosaccharide mit biologischer aktivität und verfahren zur herstellung aus glykosaminoglykanen
DE2318767A1 (de) Triamcinolon-derivat, verfahren zu seiner herstellung und dieses enthaltende arzneimittel
DE1951012A1 (de) Ester der 7-(alpha-Amino-alpha-phenylacctamido)-3-methyl-delta?-cephem-4-carbonsaeure
DE69124699T2 (de) Neues salicylsäure-maltol-konjugat
DE2238923A1 (de) Acylierte n(6)-aralkyl-adenosinderivate und verfahren zur herstellung derselben
DE940828C (de) Verfahren zur Herstellung von Estern des Penicillins mit Phenolen und Thiophenolen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee